QQQ   305.25 (+0.55%)
AAPL   153.05 (+0.87%)
MSFT   264.27 (+2.92%)
META   189.07 (+1.62%)
GOOGL   105.05 (+2.09%)
AMZN   99.63 (-2.50%)
TSLA   194.37 (-0.20%)
NVDA   217.47 (+3.12%)
NIO   10.70 (-2.10%)
BABA   104.13 (-1.25%)
AMD   83.83 (+0.18%)
T   19.28 (-1.53%)
F   13.24 (+0.76%)
MU   60.59 (+1.02%)
CGC   2.79 (-5.42%)
GE   80.96 (-1.69%)
DIS   109.81 (-0.05%)
AMC   6.26 (-7.94%)
PFE   43.38 (-0.87%)
PYPL   81.94 (-0.47%)
NFLX   357.89 (-0.99%)
QQQ   305.25 (+0.55%)
AAPL   153.05 (+0.87%)
MSFT   264.27 (+2.92%)
META   189.07 (+1.62%)
GOOGL   105.05 (+2.09%)
AMZN   99.63 (-2.50%)
TSLA   194.37 (-0.20%)
NVDA   217.47 (+3.12%)
NIO   10.70 (-2.10%)
BABA   104.13 (-1.25%)
AMD   83.83 (+0.18%)
T   19.28 (-1.53%)
F   13.24 (+0.76%)
MU   60.59 (+1.02%)
CGC   2.79 (-5.42%)
GE   80.96 (-1.69%)
DIS   109.81 (-0.05%)
AMC   6.26 (-7.94%)
PFE   43.38 (-0.87%)
PYPL   81.94 (-0.47%)
NFLX   357.89 (-0.99%)
QQQ   305.25 (+0.55%)
AAPL   153.05 (+0.87%)
MSFT   264.27 (+2.92%)
META   189.07 (+1.62%)
GOOGL   105.05 (+2.09%)
AMZN   99.63 (-2.50%)
TSLA   194.37 (-0.20%)
NVDA   217.47 (+3.12%)
NIO   10.70 (-2.10%)
BABA   104.13 (-1.25%)
AMD   83.83 (+0.18%)
T   19.28 (-1.53%)
F   13.24 (+0.76%)
MU   60.59 (+1.02%)
CGC   2.79 (-5.42%)
GE   80.96 (-1.69%)
DIS   109.81 (-0.05%)
AMC   6.26 (-7.94%)
PFE   43.38 (-0.87%)
PYPL   81.94 (-0.47%)
NFLX   357.89 (-0.99%)
QQQ   305.25 (+0.55%)
AAPL   153.05 (+0.87%)
MSFT   264.27 (+2.92%)
META   189.07 (+1.62%)
GOOGL   105.05 (+2.09%)
AMZN   99.63 (-2.50%)
TSLA   194.37 (-0.20%)
NVDA   217.47 (+3.12%)
NIO   10.70 (-2.10%)
BABA   104.13 (-1.25%)
AMD   83.83 (+0.18%)
T   19.28 (-1.53%)
F   13.24 (+0.76%)
MU   60.59 (+1.02%)
CGC   2.79 (-5.42%)
GE   80.96 (-1.69%)
DIS   109.81 (-0.05%)
AMC   6.26 (-7.94%)
PFE   43.38 (-0.87%)
PYPL   81.94 (-0.47%)
NFLX   357.89 (-0.99%)

JP Morgan Cazenove Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at JP Morgan Cazenove. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by JP Morgan Cazenove.

MarketRank evaluates a company based on community opinion, dividend strength, institutional and insider ownership, earnings and valuation, and analysts forecasts.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyDateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
LivePerson, Inc. stock logo
LPSN
LivePerson
2/25/2022Downgraded byJP Morgan CazenoveOverweight -> Neutral$60.00 -> $21.00High
KBC Group NV stock logo
KBCSY
KBC Group
10/6/2021Target Raised byJP Morgan CazenoveAnalyst Raul SinhaOverweight€79.00 -> €85.00Low
The Interpublic Group of Companies, Inc. stock logo
IPG
Interpublic Group of Companies
10/5/2021Target Raised byJP Morgan CazenoveAnalyst Alexia QuadraniOverweight$38.00 -> $43.00Medium
Netflix, Inc. stock logo
NFLX
Netflix
9/8/2021Target Raised byJP Morgan CazenoveAnalyst Doug AnmuthOverweight$625.00 -> $705.00Low
Société Générale Société anonyme stock logo
SCGLY
Société Générale Société anonyme
6/16/2021Upgraded byJP Morgan CazenoveAnalyst Kian AbouhosseinOverweightLow
Barclays PLC stock logo
BCS
Barclays
6/16/2021Upgraded byJP Morgan CazenoveAnalyst Kian AbouhosseinOverweightLow
The New York Times Company stock logo
NYT
New York Times
4/30/2018Reiterated byJP Morgan CazenoveOverweightHigh
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
4/28/2016Reiterated byJP Morgan CazenoveOverweight $15.00N/A
Banco Santander, S.A. stock logo
SAN
Banco Santander
4/25/2016Upgraded byJP Morgan CazenoveNeutral -> OverweightN/A
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
2/24/2016Target Lowered byJP Morgan CazenoveOutperform -> Buy$71.00 -> $67.00N/A
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
2/5/2016Downgraded byJP Morgan CazenoveBuy -> NeutralN/A
Antero Midstream Co. stock logo
AM
Antero Midstream
2/5/2016Reiterated byJP Morgan CazenoveUnderweight$19.00 -> $25.00N/A
T. Rowe Price Group, Inc. stock logo
TROW
T. Rowe Price Group
1/15/2016Reiterated byJP Morgan CazenoveUnderweight$74.00 -> $68.00N/A
Lloyds Banking Group plc stock logo
LYG
Lloyds Banking Group
12/3/2015Reiterated byJP Morgan CazenoveBuyN/A
Barclays PLC stock logo
BCS
Barclays
11/25/2015Reiterated byJP Morgan CazenoveBuyN/A
GSK plc stock logo
GSK
GSK
11/17/2015Reiterated byJP Morgan CazenoveNeutral GBX 1,370N/A

MarketBeat Community Rating for JP Morgan Cazenove

Community Ranking:  2.8 out of 5 (
2.8 of 5 stars)
Outperform Votes:  17,998 (Vote Outperform)
Underperform Votes:  14,413 (Vote Underperform)
Total Votes:  32,411
MarketBeat's community ratings are surveys of what our community members think about JP Morgan Cazenove and other research firms. Vote "Outperform" if you believe JP Morgan Cazenove's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe JP Morgan Cazenove's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools